F18-FDG-PET/CT for evaluation of intraductal papillary mucinous neoplasms (IPMN): a review of the literature

Jpn J Radiol. 2013 Apr;31(4):229-36. doi: 10.1007/s11604-012-0176-2. Epub 2013 Jan 12.

Abstract

Intraductal papillary mucinous neoplasms (IPMN) are intraductal mucin-producing neoplasms with tall columnar, mucin-containing epithelium, with or without papillary projections, involving the main pancreatic duct and/or major side branches. They account for approximately 25 % of all cystic neoplasms and can be subdivided into benign lesions, borderline lesions, and carcinoma. In this clinical scenario accurate preoperative diagnosis can eliminate unnecessary surgery, which is risky and potentially harmful, yet enable effective selection of patients who are candidates for surgery. In this review we try to provide a complete evaluation of the use of F18-FDG-PET/CT for diagnosis of this neoplasm on the basis of published papers. F18-FDG-PET/CT seems to be an useful technique for preoperative work-up of patients with suspected IPMN and is an improvement over conventional imaging in distinguishing benign from malignant lesions, especially for selecting patients for surgical treatment or for long-term follow-up.

Publication types

  • Review

MeSH terms

  • Adenocarcinoma, Mucinous / diagnostic imaging*
  • Carcinoma, Pancreatic Ductal / diagnostic imaging*
  • Carcinoma, Papillary / diagnostic imaging*
  • Fluorodeoxyglucose F18
  • Humans
  • Multimodal Imaging*
  • Pancreatic Neoplasms / diagnostic imaging*
  • Positron-Emission Tomography*
  • Tomography, X-Ray Computed*

Substances

  • Fluorodeoxyglucose F18